CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Emerging Chemotherapy Targets: Insights from Advances in Glioma Treatment.
Emerging Chemotherapy Targets: Insights from Advances in Glioma Treatment.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
原发性脑肿瘤是当代研究的重要焦点。随着技术的进步以及通过新型诊断方法对病例检出率的提高,创新疗法和化疗方法不断涌现。本文探讨了胶质母细胞瘤化疗的最新进展,重点介绍了提供有价值机制见解的创新方法。文章深入探讨了胶质瘤新兴疗法的作用机制、分子靶点及未来潜力。此外,本文还概述了一系列疗法的研究,包括各种化疗药物、CAR-T 细胞疗法、靶向细胞呼吸的药物以及其他方法。同时,本文还讨论了化疗相关的挑战,包括血脑屏障、耐药性和免疫抑制,并提出了克服这些障碍的潜在解决方案。
Primary brain tumors represent a significant focus of contemporary research. With advancements in technology and the increasing detection of cases through novel diagnostic methods, innovative therapies and approaches to chemotherapy continue to emerge. The paper explores recent advancements in chemotherapy for glioblastoma, highlighting innovative approaches that provide valuable mechanistic insights. It delves into the mechanisms of action, molecular targets, and the future potential of emerging therapies for gliomas.
Additionally, this paper offers an overview investigating a range of therapies, including various chemotherapeutic agents, CAR-T cell therapies, drugs targeting cellular respiration, and other approaches.
Furthermore, the paper addresses chemotherapy-related challenges, including the blood-brain barrier, drug resistance, and immunosuppression, while proposing potential solutions to overcome these obstacles.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。